. .
Clinical Stem 3
A patient with right upper lobe adenocarcinoma progressing on biomarker-directed therapy
Learning Outcome


At the conclusion of the 3rd Clinical Stem webcast, viewers will be able to:
  1. Describe procedural strategies and rationales for molecular testing in patients with enlarging primary NSCLC and associated lymphadenopathy.
  2. Describe how to overcome some of the difficulties encountered while obtaining small samples for molecular analysis.
  3. Describe acquisition and handling techniques to optimize small specimen quality and quantity for molecular testing.
  4. Describe conservation strategies used in obtaining adequate tissue for molecular analysis.
Narrative Companion to Clinical Stem 3
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology